Fig. 1.
Representative flow cytometry profiles of CD38 expression in patients with B-CLL.
(A) Sample of patients negative for CD38 expression (less than 20%). (B) Sample of patients positive for CD38 expression (20% or more). Directly labeled antibody for CD5-PE, CD19-PerCP, and CD38-APC.